Issue link: https://www.e-digitaleditions.com/i/977310
14 May 2018 Tablets & Capsules scarce, there is a real possibility that companies that hav- en't already installed the required hardware and line sys- tems will not meet the deadlines. Widengren: Some companies maybe don't fully under- stand the purpose of serialization. For example, a com- pany may request that we send the serial numbers to them in an email or an Excel file, which would make it quite easy for an unauthorized person to access the num- bers and use them on the black market. when it comes to understanding what is really needed to comply with different markets. One of the biggest problems is that many companies think that serialization vendors have sufficient delivery capacity and that waiting to implement will lead to lower costs. However, a serialization program typically takes 6 to 9 months to implement, so companies looking to make the February 2019 EU deadline should have started this phase of their projects by now, and many have not. Given that vendor availability is becoming increasingly Jean-Marie Aulnette is vice president of Europe, the Middle East, and Africa (EMEA) sales at TraceLink. He has more than 20 years of experience in international sales and is responsible for building and leading the company's EMEA business. His main focus at TraceLink is to deliver track-and-trace solutions across EMEA pharmaceutical markets to ensure visibility, traceability, and compliance throughout the supply chain. Jean-Marie joined TraceLink in 2014 and holds a master's degree in business from Centre d'Etudes Supérieures en Management International (CESMI) Groupe ISG. John Duffin is President at Clarke Solutions and Acquire Automation, managing and directing business strategy and operations. Additionally, he sits on the board of The Clarke Companies, majority stakeholder for both corporations. John has spent his entire career with The Clarke Companies, providing leadership and experience within engineering, operations, sales and marketing. Staffan Widengren is director of corporate projects at Recipharm. He is program manager for the Recipharm global serialization project and part of a global steering committee that is working closely with Recipharm's clients to ensure that they plan and implement changes that comply with pending regulatory requirements for drug serialization. Dexter Tjoa is director of corporate strategy at Tjoapack. He is responsible for devising, implementing, and evaluating the company's mid- to long-term strategies and services, as well as overseeing the commercial, finance, and IT departments within Tjoapack. He has been with the company for two years, during which time he launched Meditraq, one of Tjoapack's sister brands which offers contract serialization services. He holds a BSc in mathematics from the University of London and a MSc in mathematics and computer science from the University of Oxford and has previously worked in the technology sector.